Spontaneously arising red cells with a McLeod-like phenotype in normal donors

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 671, Issue 1-2, 2009, Pages 1-5

  Araten, David J ^a,b   Sanders, Katie J ^a   Pu, Jeffrey ^c,d   Lee, Soohee ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; Kell proteins; Mutant frequency; Spontaneous mutation; XK gene

Indexed keywords

GLYCOPHORIN A; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL; KELL PROTEIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN CLASS A; UNCLASSIFIED DRUG; XK PROTEIN;

ARTICLE; BLOOD GROUP KELL SYSTEM; CASE REPORT; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCLEOD SYNDROME; MUTATIONAL ANALYSIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SOMATIC MUTATION; UMBILICAL CORD BLOOD; X CHROMOSOME INACTIVATION;

ADULT; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; BLOOD DONORS; ERYTHROCYTES; FETAL BLOOD; GENE FREQUENCY; HUMANS; MUTATION;

EID: 70350298971     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.03.009     Document Type: Article

References (40)

1. Albertini R., Castle K., and Borcherding W. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6617-6621
2. Morley A., Trainor K., Seshadri R., and Ryall R. Measurement of in vivo mutations in human lymphocytes. Nature 302 (1983) 155-156
3. Albertini R., Nicklas J., O'Neill J., and Robison S. In vivo somatic mutations in humans: measurement and analysis. Annu. Rev. Genet. 24 (1990) 305-326
4. Bigbee W., Langlois R., Swift M., and Jensen R. Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am. J. Hum. Genet. 44 (1989) 402-408
5. Grist S., McCarron M., Kutlaca A., Turner D., and Morley A. In vivo human somatic mutation: frequency and spectrum with age. Mut. Res. 266 (1992) 189-196
6. Kavathas P., Bach F., and DeMars R. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 4251-4255
7. Kyoizumi S., Nakamura N., Hakoda M., Awa A., Bean M., Jensen R., and Akiyama M. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow sorter. Cancer Res. 49 (1989) 581-588
8. Langlois R., Bigbee W., and Jensen R. Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Human Genet. 74 (1986) 353-362
9. Pious D., Hawley P., and Forest G. Isolation and characterization of HL-A variants in cultured human lymphoid cells. Proc. Natl. Acad. Sci. U.S.A. 70 (1973)
10. Vickers M.A., Hoy T., Lake H., Kyoizumi S., Boyse J., and Hewitt M. Estimation of mutation rate at human glycophorin A locus in hematopoietic stem cell progenitors. Environ. Mol. Mut. 39 (2002) 333-341
11. Araten D., Nafa K., Pakdeesuwan K., and Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5209-5214
12. Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L., Notaro R., and Luzzatto L. A quantitative measurement of the human somatic mutation rate. Cancer Res. 65 (2005) 8111-8117
13. Araten D.J., and Luzzatto L. The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 108 (2006) 734-736
14. Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., and Kinoshita T. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259 (1993) 1318-1320
15. Rosse W.F., and Ware R.E. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 86 (1995) 3277-3286
16. Allen F., Krabbe S., and Corcoran P. A new phenotype (McLeod) in the Kell blood-group system. Vox Sang. 6 (1961) 555-560
17. Lee S., Russo D., and Redman C. The Kell blood group system: Kell and XK membrane proteins. Semin. Hematol. 37 (2000) 113-121
18. Wimer B., Marsh W., Taswell H., and Galey W. Haematological changes associated with the McLeod phenotype of the kell blood group system. Br. J. Haematol. 36 (1977) 219-224
19. Ballas S., Bator S., Aubuchon J., Marsh W., Sharp D., and Toy E. Abnormal membrane physical properties of red cells in McLeod syndrome. Transfusion 30 (1990) 722-727
20. Singleton B., Green C., Renaud S., Fuhr P., Poole J., and Daniels G. McLeod syndrome resulting from a novel XK mutation. Br. J. Haematol. 122 (2003) 682-685
21. Jung H., Hergersberg M., Kneifel S., Alkadhi H., Schiess R., Weigell-Weber M., Daniels G., Kollias S., and Hess K. McLeod syndrome: a novel mutation & predominant psychiatric manifestations and distinct striatal imaging findings. Ann. Neurol. 49 (2001) 384-392
22. Ho M., Chelly J., Carter N., Danek A., Crocker P., and Monaco A. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77 (1994) 869-880
23. Russo D., Redman C., and Lee S. Association of XK and Kell blood group proteins. J. Biol. Chem. 273 (1998) 13950-13956
24. Carbonnet F., Hattab C., Collec E., LevanKim C., Cartron J., and Bertrand O. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br. J. Haematol. 96 (1997) 857-863
25. Hewer E., Danek A., Schoser B., Miranda M., Reichard R., Castiglioni C., Oechsner M., Goebel H., Heppner F., and Jung H. McLeod myopathy revisited: more neurogenic and less benign. Brain 130 (2007) 3285-3296
26. Danek A., Rubio J., Rampoldi L., Ho M., Dobson-Stone C., Tison F., Symmans W., Oechsner M., Kalckreuth W., Watt J., Corbett A., Hamdalla H., Marshall A., Sutton I., Dotti M., Malandrini A., Walker R., Daniels G., and Monaco A. McLeod neuroacanthocytosis: genotype and phenotype. Ann. Neurol. 50 (2001) 755-764
27. Walker R., Danek A., Uttner I., Offner R., Reid M., and Lee S. McLeod phenotype without the McLeod syndrome. Immunohematology 47 (2007) 299-305
28. Peng J., Redman C., Wu X., Song X., Walker R., Westhoff C., and Lee S. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases. Gene 392 (2007) 142-150
29. Bertelson C., Pogo A., Chaudhuri A., Marsh W., Redman C., Banerjee D., Symmans W., Simon T., Frey D., and Kunkel L. Localization of the McLeod locus (XK) Within XP21 by deletion analysis. Am. J. Human Genet. 42 (1988) 703-711
30. Frey D., Machler M., Seger R., Schmid W., and Orkin S. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus. Blood 71 (1988) 252-255
31. Russo D.C.W., Lee S., Reid M., and Redman C. Topology of Kell blood group protein and the expression of multiple antigens by transfected cells. Blood 85 (1994) 3518-3523
32. Redman C., Huima T., Robbins E., Lee S., and Marsh W. Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 74 (1989) 1826-1835
33. Collec E., Colin Y., Carbonnet F., Hattab C., Bertrand O., Cartron J., and Kim C.V. Structure and expression of the mouse homologue of the XK gene. Immunogenetics 50 (1990) 16-21
34. Lee S., Russo D., Pu J., Ho M., and Redman C. The mouse Kell blood group gene (Kel): cDNA sequence, genomic organization, expression, and enzymatic function. Immunogenetics 52 (2000) 53-62
35. Lee S., Sha Q., Caldenda G., and Peng J. Expression profiles of mouse Kell, XK, XPLAC mRNA. J. Histochem. Cytochem. 55 (2007) 365-374
36. Hu R., Mukhina G.L., Piantadosi S., Barber J.P., Jones R.J., and Brodsky R.A. PIG-A mutations in normal hematopoiesis. Blood 105 (2005) 3848-3854
37. Ware R.E., Pickens C.V., DeCastro C.M., and Howard T.A. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes. Exp. Hematol. 29 (2001) 1403-1409
38. Green M.H.L., O'Neill J.P., and Cole J. Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mut. Res. 334 (1995) 323-339
39. Morley A., Cox S., and Holliday R. Human lymphocytes resistant to 6-thioguanine increase with age. Mech. Ageing Dev. 19 (1982) 21-26
40. Trainor K., Wigmore D., Chrysostomou A., Dempsey J., Seshadri R., and Morely A. Mutation frequency in human lymphocytes increases with age. Mech. Ageing Dev. 27 (1984) 83-86